4.8 Review

Advances in spray products for skin regeneration

Journal

BIOACTIVE MATERIALS
Volume 16, Issue -, Pages 187-203

Publisher

KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2022.02.023

Keywords

Skin; Spray; Tissue engineering; Fibrin; Hydrogel

Funding

  1. Fundacion Mutua Madrilena [FMM-AP17196-2019]
  2. Consejeria de Economia, Conocimiento, Empresas y Universidad de la Junta de Andalucia (ERDF funds) [B-CTS-230-UGR18, PY18-2470, A-CTS-180-UGR20, SOMM17-6109, PYC20 RE 015 UGR, P18-FR-2465]
  3. Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, ERDF funds [DTS21/00098, DTS19/00145]

Ask authors/readers for more resources

Skin sprays, an innovative technique for treating acute and chronic wounds, offer great potential for delivering cells and hydrogels. Compared to conventional treatments, they have advantages such as ease of application, the ability to treat large wound areas, and uniform distribution of materials. This article reviews the latest advances in skin spray technology, including investigational and commercially available products, and discusses regulatory pathways and clinical trials for different skin diseases.
To date, skin wounds are still an issue for healthcare professionals. Although numerous approaches have been developed over the years for skin regeneration, recent advances in regenerative medicine offer very promising strategies for the fabrication of artificial skin substitutes, including 3D bioprinting, electrospinning or spraying, among others. In particular, skin sprays are an innovative technique still under clinical evaluation that show great potential for the delivery of cells and hydrogels to treat acute and chronic wounds. Skin sprays present significant advantages compared to conventional treatments for wound healing, such as the facility of application, the possibility to treat large wound areas, or the homogeneous distribution of the sprayed material. In this article, we review the latest advances in this technology, giving a detailed description of investigational and currently commercially available acellular and cellular skin spray products, used for a variety of diseases and applying different experimental materials. Moreover, as skin sprays products are subjected to different classifications, we also explain the regulatory pathways for their commercialization and include the main clinical trials for different skin diseases and their treatment conditions. Finally, we argue and suggest possible future trends for the biotechnology of skin sprays for a better use in clinical dermatology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available